Epstein-barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: A contribution to increased tumor incidence in epithelial cells

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 3088-3099

  Yu, Haibo ^a   Lu, Jianhong ^a   Zuo, Lielian ^a   Yan, Qijia ^a   Yu, Zhengyuan ^a   Li, Xiayu ^a   Huang, Jin ^a   Zhao, Lian ^a   Tang, Hailin ^a   Luo, Zhaohui ^a   Liao, Qianjin ^a   Zeng, Zhaoyang ^a   Zhang, Junyi ^b   Li, Guiyuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; MICRORNA; MICRORNA 203; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; UPREGULATION; VIRUS GENOME;

ANIMALS; DOWN-REGULATION; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; VIRAL MATRIX PROTEINS; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 84863230385     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05901-11     Document Type: Article

References (55)

1. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
2. Bo J, et al. 2011. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J. 278:786 -792.
3. Bornkamm GW, Hammerschmidt W. 2001. Molecular virology of Epstein-Barr virus. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356:437- 459.
4. Bose S, et al. 2009. The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma. J. Pathol. 217:345-352.
5. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. 2003. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113:25-36.
6. Bueno MJ, et al. 2008. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13: 496-506.
7. Cameron JE, et al. 2008. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 382:257-266.
8. Cameron JE, et al. 2008. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J. Virol. 82:1946 -1958.
9. Chen CZ, Li L, Lodish HF, Bartel DP. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83- 86.
10. Chen DS, et al. 1997. Retroviral vector-mediated transfer of an antisense cyclin G1 construct inhibits osteosarcoma tumor growth in nude mice. Hum. Gene Ther. 8:1667-1674.
11. Chen HC, et al. 2009. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br. J. Cancer 100:1002-1011.
12. Chong JL, et al. 2009. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development. Mol. Cell. Biol. 29:414-424.
13. Craig VJ, Cogliatti SB, Rehrauer H, Wundisch T, Muller A. 2011. Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. Cancer Res. 71: 3616-3624.
14. Dawson CW, Rickinson AB, Young LS. 1990. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 344:777-780.
15. Delecluse HJ, Hammerschmidt WW. 2000. The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy. Mol. Pathol. 53: 270-279.
16. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W. 1998. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc. Natl. Acad. Sci. U. S. A. 95:8245-8250.
17. Eliopoulos AG, Young LS. 2001. LMP1 structure and signal transduction. Semin. Cancer Biol. 11:435- 444.
18. Faber J, Gregory RI, Armstrong SA. 2008. Linking miRNA regulation to BCR-ABL expression: the next dimension. Cancer Cell 13:467- 469.
19. Feber A, et al. 2008. MicroRNA expression profiles of esophageal cancer. J. Thorac. Cardiovasc. Surg. 135:255-260.
20. Gatto G, et al. 2008. Epstein-Barr virus latent membrane protein 1 transactivates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res. 36:6608-6619.
21. Glaser R, et al. 1989. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc. Natl. Acad. Sci. U. S. A. 86:9524 -9528.
22. Gordon EM, et al. 2000. Inhibition of metastatic tumor growth in nude mice by portal vein infusions of matrix-targeted retroviral vectors bearing a cytocidal cyclin G1 construct. Cancer Res. 60:3343-3347.
23. Imig J, et al. 2011. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res. 39:1880 -1893.
24. Iorio MV, Croce CM. 2009. MicroRNAs in Cancer: Small molecules with a huge impact. J. Clin. Oncol. 27:5848 -5856.
25. Jensen MR, et al. 2003. Reduced hepatic tumor incidence in cyclin G1-deficient mice. Hepatology 37:862- 870.
26. Kaye KM, Izumi KM, Kieff E. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. U. S. A. 90:9150 -9154.
27. Li HM, et al. 2004. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells. Oncogene 23:4488-4494.
28. Li QX, et al. 1992. Epstein-Barr virus infection and replication in a human epithelial cell system. Nature 356:347-350.
29. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR. 2010. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J. Virol. 84:11670 -11678.
30. Lo KW, To KF, Huang DP. 2004. Focus on nasopharyngeal carcinoma. Cancer Cell 5:423- 428.
31. Lu J, et al. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834-838.
32. Lu JH, et al. 2010. Epstein-Barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance. Lab. Invest. 90:196 -209.
33. Mainou BA, Everly DN, Jr, Raab-Traub N. 2007. Unique signaling properties of CTAR1 in LMP1-mediated transformation. J. Virol. 81: 9680-9692.
34. Mathe EA, et al. 2009. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin. Cancer Res. 15:6192- 6200.
35. McKenna DJ, McDade SS, Patel D, McCance DJ. 2010. MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J. Virol. 84:10644 -10652.
36. Mei YP, et al. 2007. Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells. Cell Cycle 6:1379 -1385.
37. Meisler AI. 1996. Epstein-Barr virus and nasopharyngeal cancer. N. Engl. J. Med. 334:122-123.
38. Melar-New M, Laimins LA. 2010. Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J. Virol. 84:5212-5221.
39. Moorthy RK, Thorley-Lawson DA. 1993. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J. Virol. 67:1638 -1646.
40. Ohtsuka T, Jensen MR, Kim HG, Kim KT, Lee SW. 2004. The negative role of cyclin G in ATM-dependent p53 activation. Oncogene 23:5405- 5408.
41. Sengupta S, et al. 2008. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc. Natl. Acad. Sci. U. S. A. 105:5874 -5878.
42. Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse HJ. 2006. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 103:7065-7070.
43. Sharma N, et al. 2006. Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformation. J. Biol. Chem. 281:36124 -36131.
44. Shinozaki A, et al. 2010. Downregulation of microRNA-200 in EBVassociated gastric carcinoma. Cancer Res. 70:4719-4727.
45. Sonkoly E, et al. 2007. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2:e610.
46. Sugden B, Mark W. 1977. Clonal transformation of adult human leukocytes by Epstein-Barr virus. J. Virol. 23:503-508.
47. Tang YL, et al. 2007. Lytic replication and inductive production of recombinant Epstein-Barr virus visualized. Prog. Biochem. Biophys. 34: 418-424.
48. Viticchie G, et al. 2011. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 10:1121-1131.
49. Wang D, Liebowitz D, Kieff E. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831- 840.
50. Wang D, et al. 1988. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J. Virol. 62:4173- 4184.
51. Wang LT, et al. 2011. Functional interaction of Ugene and EBV infection mediates tumorigenic effects. Oncogene 30:2921-2932.
52. Wu L, et al. 2001. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414:457- 462.
53. Yi R, Poy MN, Stoffel M, Fuchs E. 2008. A skin microRNA promotes differentiation by repressing " stemness." Nature 452:225-229.
54. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4:757-768.
55. Yu Z, et al. 2011. A precise excision of the complete Epstein-Barr virus genome in a plasmid based on a bacterial artificial chromosome. J. Virol. Methods 176:103-107.